INMedD_logo
Yellow Bar

Paul England

Paul England received his B.Sc. and Ph.D. from the University of Bristol (UK), and after a post-doctoral position with Prof. Edwin Krebs at the University of California, Davis from 1971-73, he returned to the University of Bristol as a Lecturer in Biochemistry.  His research speciality was the role of protein phosphorylation in the control of muscle function.   In 1985 he joined Smith, Kline & French R&D (subsequently SmithKline Beecham) in the Drug Discovery division.  From 1994-1997 he was Vice President Molecular Screening Technologies, in which role he established and managed SB’s entire high throughput screening activities and enzymology worldwide.   From 1998-2000 he was Senior Vice President Research at Aurora Biosciences Corp. in San Diego, with responsibility for assay development and screening.  He is currently involved with a number of small companies in the drug discovery area in the UK, including being Chief Executive Officer of ProXara Biotechnology Ltd.

Back to Directors

Yellow Bar